{
    "Trade/Device Name(s)": [
        "INSTANT-ViEw\u00ae BUP/NBUP Urine Test (Cassette, Dip-Strip)",
        "INSTANT-VERDICT\u00ae BUP/NBUP Urine Test (Cassette, Dip-Strip)",
        "INSTANT-CONFIRMATORY\u00ae BUP/NBUP Urine Test (Cassette, Dip-Strip)"
    ],
    "Submitter Information": "Alfa Scientific Designs, Inc.",
    "510(k) Number": "K060527",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG"
    ],
    "Summary Letter Date": "July 14, 2006",
    "Summary Letter Received Date": "July 17, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Buprenorphine",
        "Norbuprenorphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "Lateral flow chromatographic assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test",
        "Cassette",
        "Dip-Strip"
    ],
    "Document Summary": "FDA 510(k) summary for INSTANT-ViEw, INSTANT-VERDICT, and INSTANT-CONFIRMATORY BUP/NBUP urine tests for qualitative detection of buprenorphine and norbuprenorphine using immunoassay",
    "Indications for Use Summary": "Qualitative immunoassay for rapid preliminary detection of buprenorphine and norbuprenorphine in human urine; for health care professional use only",
    "fda_folder": "Toxicology"
}